Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.31 |
| ▸ | TET3 | O43151 | 1/20 | 0.31 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 3/20 | 0.30 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28199700 | 0.84 | TDP1 (0.35) | TDP1ALDH1A1THRBTSHR | |
| Methacrylic Acid SCHEMBL28652423 | 0.81 | TDP1 (0.36) | TDP1ALDH1A1FFAR3THRBTET2 | |
| Methacrylic Acid SCHEMBL9717202 | 0.81 | TSHR (0.41) | TDP1ALDH1A1FFAR3THRBTET2 | |
| Methacrylic Acid SCHEMBL3472675 | 0.81 | TDP1 (0.36) | TDP1ALDH1A1FFAR3THRBTET2 | |
| Methacrylic Acid SCHEMBL28339981 | 0.80 | — | — | |
| Methacrylic Acid SCHEMBL9717204 | 0.80 | TDP1 (0.40) | TDP1ALDH1A1FFAR3THRBTET2 | |
| Methacrylic Acid SCHEMBL129271 | 0.80 | TDP1 (0.44) | TDP1ALDH1A1FFAR3THRBTET2 | |
| Methacrylic Acid SCHEMBL30721692 | 0.80 | TDP1 (0.44) | TDP1ALDH1A1FFAR3THRBTET2 | |
| Methacrylic Acid SCHEMBL346724 | 0.80 | TDP1 (0.44) | TDP1ALDH1A1FFAR3THRBTET2 | |
| Methacrylic Acid SCHEMBL2581850 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037193-A | Cured product, optical element, optical device, and imaging device | 佳能株式会社 | 2026-05-15 | — | — | CN | disclosed |
| US-20260110823-A1 | OPTICAL ELEMENT, OPTICAL APPARATUS, IMAGING APPARATUS, AND COMPOUND | CANON KK (JP) | 2026-04-23 | — | — | US | disclosed |
| US-12529822-B2 | Optical element, optical apparatus, imaging apparatus, and compound | CANON KABUSHIKI KAISHA (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12479976-B2 | Cured product, optical element, optical apparatus, and imaging apparatus | CANON KABUSHIKI KAISHA (JP) | 2025-11-25 | — | — | US | disclosed |
| US-20250034294-A1 | CURED PRODUCT, OPTICAL ELEMENT, OPTICAL APPARATUS, AND IMAGE PICKUP APPARATUS | CANON KK (JP) | 2025-01-30 | — | — | US | disclosed |
| US-12146011-B2 | Cured product, optical element, optical apparatus, and image pickup apparatus | CANON KABUSHIKI KAISHA (JP) | 2024-11-19 | — | — | US | disclosed |
| EP-3591441-B1 | OPTICAL ELEMENT, MATERIAL, OPTICAL DEVICE AND COMPOUND | CANON KK (JP) | 2024-11-06 | — | — | EP | disclosed |
| EP-4095167-B1 | CURED PRODUCT, OPTICAL ELEMENT, OPTICAL APPARATUS, AND IMAGE PICKUP APPARATUS | CANON KK (JP) | 2024-08-28 | — | — | EP | disclosed |
| US-12066593-B2 | (Meth)acrylate compound | CANON KABUSHIKI KAISHA (JP) | 2024-08-20 | — | — | US | disclosed |
| CN-114437269-B | Optical element, optical device, imaging device, and compound | 佳能株式会社 | 2024-06-07 | — | — | CN | disclosed |
| US-6300464-B2 | HIGH HEAT RESISTANCE AND REFRACTIVE INDEX, LOW SPECIFIC GRAVITY; POLYMERS CONTAINING THIO(EPOXY) AND AT LEAST ONE DISULFIDE BOND | MITSUI CHEMICAL, INC. (JP) | 2001-10-09 | — | — | US | disclosed |
| US-6265510-B1 | OPTICS; LENSES | MITSUI CHEMICALS, INC. (JP) | 2001-07-24 | — | — | US | disclosed |
| US-20010002413-A1 | Polymerizable composition | MORIJIRI HIROYUKI (JP) | 2001-05-31 | — | — | US | disclosed |
| US-6204311-B1 | (THIO)EPOXY COMPOUND HAVING AT LEAST ONE INTRAMOLECULAR DISULFIDE BOND AND A CURING CATALYST. | MITSUI CHEMICALS, INC. (JP) | 2001-03-20 | — | — | US | disclosed |
| EP-0810210-B1 | Thiol and sulfur-containing o-(meth)acrylate compounds and use thereof | MITSUI CHEMICALS INC (JP) | 2001-01-10 | — | — | EP | disclosed |
| EP-1058133-A2 | Polymerizable composition and process for producing optical resin comprising the same | Mitsui Chemicals, Inc. (JP) | 2000-12-06 | — | — | EP | disclosed |
| US-6114485-A | STARTING MATERIAL FOR A RESIN COMPOSITION USED IN OPTICAL APPLICATIONS SUCH AS A LENS | MITSUI CHEMICALS, INC. (JP) | 2000-09-05 | — | — | US | disclosed |
| EP-0942027-A2 | A polymerizable composition | Mitsui Chemicals, Inc. (JP) | 1999-09-15 | — | — | EP | disclosed |
| US-5916987-A | OPTICAL RESIN; LENSES | MITSUI CHEMICALS, INC. (JP) | 1999-06-29 | — | — | US | disclosed |
| EP-0810210-A2 | Thiol and sulfur-containing o-(meth)acrylate compounds and use thereof | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260110823-A1 | OPTICAL ELEMENT, OPTICAL APPARATUS, IMAGING APPARATUS, AND COMPOUND | RAD51, PIEZO1, ZYX | TDP1 3927/4885ALDH1A1 1504/4885FFAR3 375/4885 |
| US-12066593-B2 | (Meth)acrylate compound | MTX1, METTL3, MET | TDP1 3311/4885ALDH1A1 183/4885FFAR3 3080/4885 |
| US-12529822-B2 | Optical element, optical apparatus, imaging apparatus, and compound | RAD51, SEM1, PSMA3 | TDP1 3381/4885ALDH1A1 1261/4885FFAR3 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.